Enlila Sağlık Pays $24 Million for Majority Stake in US Biotech Crescenta

Turkish venture affiliate acquires control of Princeton-founded firm via capital increase to accelerate clinical programs.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.